{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T12:55:50Z","timestamp":1761742550385},"reference-count":73,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2004,12,1]],"date-time":"2004-12-01T00:00:00Z","timestamp":1101859200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Infectious Disease Clinics of North America"],"published-print":{"date-parts":[[2004,12]]},"DOI":"10.1016\/j.idc.2004.07.010","type":"journal-article","created":{"date-parts":[[2005,4,18]],"date-time":"2005-04-18T14:53:30Z","timestamp":1113836010000},"page":"963-974","source":"Crossref","is-referenced-by-count":9,"title":["Re-evaluation of the therapy of severe pneumonia caused by Streptococcus pneumoniae"],"prefix":"10.1016","volume":"18","author":[{"suffix":"Jr.","given":"Joseph F.","family":"Plouffe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel R.","family":"Martin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.idc.2004.07.010_bib1","first-page":"759","article-title":"Pneumococcal bacteremia with special reference to bacteremic pneumococcal pneumonia","volume":"60","author":"Austrian","year":"1964","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2004.07.010_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0163-4453(05)80029-5","article-title":"Bacteraemic pneumococcal pneumonia: a continuously evolving disease","volume":"24","author":"Marrie","year":"1992","journal-title":"J Infect"},{"key":"10.1016\/j.idc.2004.07.010_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s001340050807","article-title":"Severe community-acquired pneumococcal pneumonia\u2014what might be done better","volume":"25","author":"Ewig","year":"1999","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.idc.2004.07.010_bib4","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1001\/archinte.160.10.1399","article-title":"Management of community- acquired pneumonia in the era pneumococcal resistance: a report from the drug-resistant Streptococcus pneumoniae therapeutic working group","volume":"160","author":"Heffelfinger","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2004.07.010_bib5","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.1016\/S0002-9343(99)00098-4","article-title":"Bacteremic pneumococcal pneumonia in one American City: a 20-year longitudinal study, 1978-1997","volume":"107","author":"Mufson","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/j.idc.2004.07.010_bib6","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1001\/archinte.161.15.1837","article-title":"Monotherapy may be suboptimal for severe bacteremic pneumococcal pneumonia","volume":"161","author":"Waterer","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2004.07.010_bib7","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1086\/367541","article-title":"Addition of a macrolide to a beta-lactam-based empirical antibiotic regimen is associated with lower in-hospital mortality for patients with bacteremic pneumococcal pneumonia","volume":"36","author":"Martinez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib8","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1086\/313959","article-title":"Canadian guidelines for the initial management of community-acquired pneumonia\u2014an evidence-based update by the Canadian Infectious Disease Society and the Canadian Thoracic Society: the Canadian CAP working group","volume":"31","author":"Mandell","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib9","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.1164\/ajrccm.163.7.at1010","article-title":"Guidelines for the management of adults with community acquired pneumonia: diagnosis, assessment of severity, antimicrobial therapy, and prevention","volume":"163","author":"Niederman","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idc.2004.07.010_bib10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/0036554021000026965","article-title":"Swedish Infectious Diseases Society Pneumonia Study Group: management of patients with community-acquired pneumonia treated in hospital in Sweden","volume":"34","author":"Hedlund","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib11","doi-asserted-by":"crossref","first-page":"1404","DOI":"10.1086\/380488","article-title":"Update of practice guidelines for the management of community-acquired pneumonia in immunocompetent adults","volume":"37","author":"Mandell","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1093\/clinids\/11.4.586","article-title":"Community-acquired pneumonia requiring hospitalization: 5-year prospective study","volume":"11","author":"Marrie","year":"1989","journal-title":"Rev Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib13","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/00005792-199009000-00004","article-title":"New and emerging etiologies for community-acquired pneumonia with implications for therapy: a prospective multi-center study of 359 cases","volume":"69","author":"Fang","year":"1990","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.idc.2004.07.010_bib14","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1136\/thx.51.2.179","article-title":"Multiple pathogens in adult patients admitted with community-acquired pneumonia: a one year prospective study of 346 consecutive patients","volume":"5","author":"Lieberman","year":"1996","journal-title":"Thorax"},{"key":"10.1016\/j.idc.2004.07.010_bib15","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1001\/archinte.157.15.1709","article-title":"Incidence of community-acquired pneumonia requiring hospitalization","volume":"157","author":"Marston","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2004.07.010_bib16","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1086\/319746","article-title":"Microbial etiology of community-acquired pneumonia in the adult population of 4 municipalities in eastern Finland","volume":"32","author":"Jokinen","year":"2001","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib17","doi-asserted-by":"crossref","first-page":"20s","DOI":"10.1183\/09031936.02.00702002","article-title":"Community-acquired pneumonia in Europe: causative pathogens and resistance patterns","volume":"36","author":"Woodhead","year":"2002","journal-title":"Eur Respir J Suppl"},{"key":"10.1016\/j.idc.2004.07.010_bib18","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM198607173150305","article-title":"A new Chlamydia psittaci strain, TWAR, isolated in acute respiratory tract infections","volume":"315","author":"Grayston","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2004.07.010_bib19","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1093\/infdis\/174.3.456","article-title":"Respiratory syncytial virus (RSV) may be an important cause of community-acquired lower respiratory infection among hospitalized adults","volume":"174","author":"Dowell","year":"1996","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib20","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0891-5520(05)70199-9","article-title":"The role of atypical pathogens: Mycoplasma pneumoniae, Chlamydia pneumoniae and Legionella pneumonia in respiratory infection","volume":"12","author":"File","year":"1998","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/j.idc.2004.07.010_bib21","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1086\/520227","article-title":"Clinical characteristics of C. pneumoniae infection as the sole cause of community-acquired pneumonia","volume":"29","author":"File","year":"1999","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1086\/520142","article-title":"Parainfluenza virus infection among adults hospitalized for lower respiratory tract infection","volume":"29","author":"Marx","year":"1999","journal-title":"Clin Infec Dis"},{"issue":"Suppl 2","key":"10.1016\/j.idc.2004.07.010_bib23","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1086\/314058","article-title":"Importance of atypical pathogens of community-acquired pneumonia","volume":"31","author":"Plouffe","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib24","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1086\/368163","article-title":"Role of neuraminidase in lethal synergism between influenza virus and Streptococcus pneumoniae","volume":"187","author":"McCullers","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib25","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1080\/0036554021000026961","article-title":"Moraxella catarrhalis bacteraemia associated with Mycoplasma pneumoniae infection and pneumonia","volume":"34","author":"Bodasing","year":"2002","journal-title":"Scand J Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib26","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1086\/341771","article-title":"Legionnaires disease with bacteremic coinfection","volume":"35","author":"Tan","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib27","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1001\/jama.275.3.194","article-title":"CBPIS study group: Bacteremia with Streptococcus pneumoniae: implications for therapy and prevention","volume":"275","author":"Plouffe","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2004.07.010_bib28","doi-asserted-by":"crossref","first-page":"1965","DOI":"10.1001\/archinte.157.17.1965","article-title":"Adult bacteremic pneumococcal pneumonia in a community teaching hospital, 1992-1996: a detailed analysis of 108 cases","volume":"157","author":"Watanakunakorn","year":"1997","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2004.07.010_bib29","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1001\/jama.278.16.1333","article-title":"Cost-effectiveness of vaccination against pneumococcal bacteremia among elderly people","volume":"278","author":"Sisk","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2004.07.010_bib30","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jama.275.2.134","article-title":"Prognosis and outcomes of patients with community-acquired pneumonia","volume":"275","author":"Fine","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2004.07.010_bib31","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1001\/jama.278.23.2080","article-title":"Quality of care, process and outcomes in elderly patients with pneumonia","volume":"278","author":"Meehan","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2004.07.010_bib32","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1001\/archinte.159.21.2562","article-title":"Association between antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia","volume":"159","author":"Gleason","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2004.07.010_bib33","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1378\/chest.116.5.1278","article-title":"The impact of blood cultures on antibiotic therapy in pneumococcal pneumonia","volume":"116","author":"Waterer","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.idc.2004.07.010_bib34","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1378\/chest.116.5.1153","article-title":"Blood cultures for community-acquired pneumonia: no place to skimp!","volume":"116","author":"Bryan","year":"1999","journal-title":"Chest"},{"key":"10.1016\/j.idc.2004.07.010_bib35","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1097\/00005792-200007000-00002","article-title":"Bacteremic and nonbacteremic pneumococcal pneumonia: a prospective study","volume":"79","author":"Musher","year":"2000","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/j.idc.2004.07.010_bib36","doi-asserted-by":"crossref","first-page":"3495","DOI":"10.1128\/JCM.39.10.3495-3498.2001","article-title":"Evaluation of a rapid immunochromatographic test for detection of Streptococcus pneumoniae antigen in urine samples from adults with community-acquired pneumonia","volume":"39","author":"Murdoch","year":"2001","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2004.07.010_bib37","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1128\/JCM.41.7.2810-2813.2003","article-title":"Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation","volume":"41","author":"Smith","year":"2003","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2004.07.010_bib38","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1128\/JCM.41.5.2161-2163.2003","article-title":"Usefulness of urinary antigen detection by an immunochromatographic test for diagnosis of pneumococcal pneumonia in children","volume":"41","author":"Dominguez","year":"2000","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.idc.2004.07.010_bib39","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1086\/345852","article-title":"Evaluation of the immunochromatographic Binax NOW assay for detection of Streptococcus pneumoniae urinary antigen in a prospective study of community-acquired pneumonia in Spain","volume":"36","author":"Gutierrez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib40","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1378\/chest.103.3.710","article-title":"Deaths in bacteremic pneumococcal pneumonia: a comparison of two populations\u2014Huntington, WVa, and Stockholm, Sweden","volume":"103","author":"Ortqvist","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.idc.2004.07.010_bib41","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1378\/chest.103.3.658","article-title":"Bacteremic pneumococcal pneumonia mortality rate: is it really different in Sweden?","volume":"103","author":"Marrie","year":"1993","journal-title":"Chest"},{"key":"10.1016\/j.idc.2004.07.010_bib42","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1128\/AAC.47.3.1151-1153.2003","article-title":"Lack of synergy of erythromycin combined with penicillin or cefotaxime against Streptococcus pneumoniae in vitro","volume":"47","author":"Lin","year":"2003","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2004.07.010_bib43","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1001\/archinte.1951.03810100073006","article-title":"Treatment of pneumococcal meningitis with penicillin compared with penicillin and aureomycin; studies including observations on an apparent antagonism between penicillin and aureomycin","volume":"88","author":"Lepper","year":"1951","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2004.07.010_bib44","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1097\/01.CCM.0000114817.58194.BF","article-title":"Prospective observational study of bacteremic pneumococcal pneumonia: effect of discordant therapy on mortality","volume":"32","author":"Lujan","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2004.07.010_bib45","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/S0732-8893(00)00181-4","article-title":"Potential importance of Legionella species in community acquired pneumonia CAP","volume":"38","author":"McNally","year":"2000","journal-title":"Diag Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib46","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1086\/342884","article-title":"Infection due to Legionella species other than L. pneuophila","volume":"35","author":"Muder","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib47","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1099\/00207713-51-3-1151","article-title":"Legionella drozanskii sp nov, Legionella rowbothamii sp nov and Legionella fallonii sp nov: three new unusual Legionella species","volume":"51","author":"Adelke","year":"2001","journal-title":"Int J Syst Evol Microbial"},{"key":"10.1016\/j.idc.2004.07.010_bib48","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3201\/eid0706.010619","article-title":"Legionella-like and other amoebal pathogens as agents of community-acquired pneumonia","volume":"7","author":"Marrie","year":"2001","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib49","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1056\/NEJM198709103171101","article-title":"and the Methylprednisolone Severe Sepsis Study Group: a controlled clinical trial of high-dose methylprednisolone in the treatment of severe sepsis and septic shock","volume":"317","author":"Bone","year":"1987","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2004.07.010_bib50","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1001\/jama.266.8.1097","article-title":"A controlled clinical trial of E5 murine monoclonal IgM antibody to endotoxin in the treatment of gram-negative sepsis","volume":"266","author":"Greenman","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2004.07.010_bib51","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jama.273.12.934","article-title":"Efficacy and safety of monoclonal antibody to human tumor necrosis factor in patients with sepsis syndrome: a randomized, controlled, double-blind, multicenter clinical trial","volume":"273","author":"Abraham","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/j.idc.2004.07.010_bib52","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1097\/00003246-199506000-00003","article-title":"A second large controlled clinical study of E5, a monoclonal antibody to endotoxin: results of a prospective, multicenter, randomized, controlled trial","volume":"23","author":"Bone","year":"1995","journal-title":"Crit Care Med"},{"key":"10.1016\/j.idc.2004.07.010_bib53","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.1056\/NEJM199105303242201","article-title":"The beneficial effects of early dexamethasone administration in infants and children with bacterial meningitis","volume":"324","author":"Odio","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2004.07.010_bib54","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1056\/NEJMoa021334","article-title":"European dexamethasone in adulthood bacterial meningitis study investigators: dexamethasone in adults with bacterial meningitis","volume":"347","author":"de Gans","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.idc.2004.07.010_bib55","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1086\/376454","article-title":"Anti-tumor necrosis factor antibody impairs the therapeutic effect of ceftriaxone in murine pneumococcal pneumonia","volume":"188","author":"Rijneveld","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib56","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1086\/383131","article-title":"Is anti-tumor necrosis factor therapy associated with increased mortality in patients with severe sepsis caused by pneumonia?","volume":"189","author":"Harbarth","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib57","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1086\/382962","article-title":"Activation of neutrophils and inhibition of the proinflammatory cytokine response by endogenous granulocyte colony stimulating factor in murine pneumococcal pneumonia","volume":"189","author":"Knapp","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib58","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1086\/520286","article-title":"Drug-resistant Streptococcus pneumoniae","volume":"26","author":"Campbell","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib59","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/374052","article-title":"TRUST Surveillance Program. Factors associated with relative rates of antimicrobial resistance among Streptococcus pneumoniae in the United States: results from the TRUST Surveillance Program (1998-2002)","volume":"36","author":"Karlowsky","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib60","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/S0732-8893(03)00015-4","article-title":"Influence of patient age on the susceptibility patterns of Streptococcus pneumoniae isolates in North America (2000-2001): report from the SENTRY Antimicrobial Surveillance Program","volume":"46","author":"Jones","year":"2003","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib61","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1086\/377534","article-title":"International Pneumococcal Study Group: an international prospective study of pneumococcal bacteremia. Correlation with in vitro resistance, antibiotics administered, and clinical outcome","volume":"37","author":"Yu","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib62","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1086\/374846","article-title":"Is azithromycin the first-choice macrolide for treatment of community-acquired pneumonia?","volume":"36","author":"Sanchez","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib63","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.1001\/archinte.159.21.2511","article-title":"The best treatment of pneumonia: new clues, but no definitive answers","volume":"159","author":"Dowell","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/j.idc.2004.07.010_bib64","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1086\/367545","article-title":"What is optimal therapy for bacteremic pneumococcal pneumonia?","volume":"36","author":"File","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"Suppl 4","key":"10.1016\/j.idc.2004.07.010_bib65","doi-asserted-by":"crossref","first-page":"S328","DOI":"10.1086\/382689","article-title":"Monotherapy versus dual therapy for community-acquired pneumonia in hospitalized patients","volume":"38","author":"Martinez","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib66","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1128\/AAC.40.9.2147","article-title":"Synergy between amoxicillin and gentamicin in combination against a highly penicillin-resistant and -tolerant strain of Streptococcus pneumoniae in a mouse neumonia model","volume":"40","author":"Darras-Joly","year":"1996","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2004.07.010_bib67","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1128\/AAC.45.1.316-318.2001","article-title":"Effective combination therapy for invasive pneumococcal pneumonia with ampicillin and intravenous immunoglobulins in a mouse model","volume":"45","author":"De Hennezel","year":"2001","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.idc.2004.07.010_bib68","doi-asserted-by":"crossref","first-page":"5240","DOI":"10.4049\/jimmunol.167.9.5240","article-title":"TNF-alpha compensates for the impaired host defense of IL-1 type I receptor-deficient mice during pneumococcal pneumonia","volume":"167","author":"Rijneveld","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/j.idc.2004.07.010_bib69","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1086\/514062","article-title":"Interleukin-6 gene-deficient mice show impaired defense against pneumococcal pneumonia","volume":"176","author":"van der Poll","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib70","doi-asserted-by":"crossref","first-page":"372","DOI":"10.4049\/jimmunol.168.1.372","article-title":"IL-18 improves the early antimicrobial host response to pneumococcal pneumonia","volume":"168","author":"Lauw","year":"2002","journal-title":"J Immunol"},{"key":"10.1016\/j.idc.2004.07.010_bib71","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1164\/rccm.200207-698OC","article-title":"Alveolar macrophages have a protective antiinflammatory role during murine pneumococcal pneumonia","volume":"167","author":"Knapp","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.idc.2004.07.010_bib72","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1086\/381392","article-title":"Improved host defense against pneumococcal pneumonia in platelet-activating factor receptor-deficient mice","volume":"189","author":"Rijneveld","year":"2004","journal-title":"J Infect Dis"},{"key":"10.1016\/j.idc.2004.07.010_bib73","doi-asserted-by":"crossref","first-page":"4925","DOI":"10.1128\/IAI.71.9.4925-4935.2003","article-title":"ZmpB, a novel virulence factor of Streptococcus pneumoniae that induces tumor necrosis factor alpha production in the respiratory tract","volume":"71","author":"Blue","year":"2003","journal-title":"Infect Immun"}],"container-title":["Infectious Disease Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552004001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0891552004001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,14]],"date-time":"2019-02-14T00:11:20Z","timestamp":1550103080000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0891552004001023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2004,12]]},"references-count":73,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2004,12]]}},"alternative-id":["S0891552004001023"],"URL":"https:\/\/doi.org\/10.1016\/j.idc.2004.07.010","relation":{},"ISSN":["0891-5520"],"issn-type":[{"value":"0891-5520","type":"print"}],"subject":[],"published":{"date-parts":[[2004,12]]}}}